Value of soluble CD14 for prognosis of progression of HIV-infection
G.R. KHASANOVA1,2, V.A. ANOKHIN1, F.I. NAGIMOVA2
Kazan State Medical University, 49 Butlerov St., Kazan, Russian Federation, 420012
Republican Center of AIDS and Infectious Diseases of Ministry of Healthcare of Tatarstan Republic, 2a Vishnevskogo St., Kazan, Russian Federation, 420097
Khasanova G.R. — Associated Professor of the Department of Pediatric Infectious Diseases, ID specialist, tel. (843) 267-8006, e-mail: gulshatra@mail.ru1
Anokhin V.A. — D. Med. Sc., Professor, Head of the Department of Pediatric Infectious Diseases, (843) 267-8100, e-mail:anokhin56@mail.ru1
Nagimova F.I. — Cand. Med. Sc., Vice-Head of the Center of AIDS and Infectious Diseases of Ministry of Health of Tatarstan Republic, tel. (843) 236-9436, e-mail: nagimova@list.ru2
Chronic activation of inflammation is an important cause of HIV-infection progression. Endotoxin of gram-negative micro organisms is one of the possible agents which cause systemic inflammation. The purpose of our research was to evaluate the prognostic value of sCD14 — the marker of endotoxin-induced activation of cells — in the HIV-infection progression. A prospective cohort study was done to assess dynamics of CD4+ cells. 89 patients were divided into 2 groups, depending on the level of sCD14 (≤2.94 or >2.94 pg/ml). The increased level of sCD14 during the whole course of disease was detected. The level of sCD14 in HIV-group was higher than the level in control group [2.95 pg/ml (95%CI 2.45-3.63) and 1.91 pg/ml (95%CI 1.67-2.22) respectively, р=0.00001]. Correlations of sCD14 and markers of inflammation were found, such as: tumor necrosis factor-α (r=0.35; p=0.007), leucocytes number (r=0.21; p=0.04) and erythrocyte sedimentation rate (r=0.27; p=0.013). Correlation of sCD14 level with markers of progression of HIV-infection was detected, such as: stage of the disease (r=0.41; p=0.00006; presence of opportunistic infections (r=0.41; p=0.00006), decrease of CD4-cells (r=-0.21; p=0.046). The analysis of results of cohort study revealed that higher levels of sCD14 predict higher speed of depletion of CD4+cells in patients without antiretroviral treatment, as well as higher rate of «lack of response» to treatment. Prognostic value of sCD14 levels in HIV-infection progression confirms the role of endotoxin of gram-negative micro organisms and the value of microbial translocation in the HIV-infection pathogenesis.
Кey words: HIV-infection, sCD14, endotoxin, inflammation.
REFERENCES
1. Brenchley J.M., Price D.A., Schacker T.W. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med., 2006, vol. 12, pp. 1365-1371.
2. Li Q., Estes J.D., Duan L. et al. Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. J Infect Dis., 2008, vol. 197, pp. 420-429.
3. Brenchley J.M., Price D.A., Douek D.C. HIV disease: fallout from a mucosal catastrophe? Nat Immunol., 2006, vol. 7, pp. 235-239.
4. Khasanova G.R., Anokhin V.A., Bikkinina O.I. et al. Intestinal disorders microbiocenosis in patients with HIV infection. Kazanskiy meditsinskiy zhurnal, 2013, vol. 94, no. 1, pp. 34-39 (in Russ.).
5. Gioannini T.L., Weiss J.P. Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells. Immunol Res., 2007, vol. 39, pp. 249-260.
6. Hiki N., Berger D., Prigl C. et al. Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria. Infect Immun., 1998, vol. 66, pp. 1135-1141.
7. Sandler N.G., Wand H., Roque A. et al. Plasma levels of soluble CD14 independently predict mortality in HIV-infection. J Infect Dis., 2011, vol. 203 (6), pp. 780-790.
8. Marchetti G., Bellistri G.M. et al. Microbial translocation is associated with sustained failure in CD4+T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS, 2008, vol. 22, pp. 2035-2038.
9. Jiang W., Lederman M.M., Hunt P. et al. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J Infect Dis., 2009, vol. 199, pp. 1177-1185.
10. Clifford G.M., Franceschi S. Cancer risk in HIV-infected persons: influence of CD4+ count. Future Oncol., 2009, vol. 5, pp. 669-678.